QuidelOrtho Receives Jefferies Upgrade to 'Buy' Rating

Market Update: Jefferies upgraded QuidelOrtho to 'Buy' from 'Hold', signaling investor confidence. Institutional holdings in QuidelOrtho have grown significantly, indicating positive sentiment among large shareholders.

Date: 12-05-2025

AI Rating: 8

**Jefferies Upgrade and Institutional Confidence**
The recent report highlights a significant upgrade from Jefferies for QuidelOrtho, moving its rating from "Hold" to "Buy." This change suggests an enhanced outlook based on various factors, likely including improved fundamentals or future growth potential as perceived by analysts at Jefferies.

Additionally, the sentiment among funds and institutional investors appears to be increasing. Notable firms have reported increases in their holdings, with T. Rowe Price Investment Management increasing its shares by 16.38% and Rubric Capital Management by 24.32%. Increased institutional investment often indicates investor confidence and can serve as a catalyst for stock price appreciation. The increased portfolio allocations by multiple funds portray a growing bullish sentiment towards QuidelOrtho.

It is important to mention that while earnings statistics such as Earnings Per Share (EPS), Revenue Growth, Net Income, Profit Margins, Free Cash Flow (FCF), and Return on Equity (ROE) are not disclosed within this specific report, the upgrade itself reflects a positive analyst sentiment that could correlate with underlying performance expectations. As institutional holdings rise and as companies draw the attention of major funds, stock prices may be positively impacted due to perceived stability and growth potential.

In conclusion, the upgrade from Jefferies, coupled with the increased stakes by multiple institutional investors, paints a constructive picture for QuidelOrtho in the short-term. Should the company deliver favorable financial results in its upcoming quarters or reveal positive developments, stock prices may likely respond favorably as well.

Stocks: QDEL